Related Experiment Video
Updated: May 25, 2026

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations
Published on: October 20, 2017
Prospective hemorrhage risk of intracerebral cavernous malformations
K D Flemming1, M J Link, T J H Christianson
1Department of Neurology, Mayo Clinic, Rochester, MN, USA. flemming.kelly@mayo.edu
Insights
Patients with intracerebral cavernous malformations (ICMs) have a significant risk of symptomatic hemorrhage, especially after a prior bleed. This risk decreases over time, but male gender and multiple ICMs are associated with increased hemorrhage risk.
Area of Science:
- Neurology
- Neurosurgery
- Radiology
Background:
- Intracerebral cavernous malformations (ICMs) are vascular malformations that can lead to symptomatic hemorrhage.
- Understanding the prospective risk and timing of hemorrhage is crucial for patient management.
Purpose of the Study:
- To describe the prospective risk and timing of symptomatic hemorrhage in a large cohort of patients with intracerebral cavernous malformations (ICMs).
Main Methods:
- Retrospective identification of patients diagnosed with ICMs between 1989 and 1999.
- Review of patient records and radiographic data, with follow-up obtained.
- Calculation of annual hemorrhage risk using incidence rates and analysis of predictive factors.
Main Results:
- A total of 292 patients with 2,035 patient-years of follow-up were analyzed.
- The overall annual hemorrhage rate was 6.19% for those with prior hemorrhage, 2.18% for those with non-hemorrhagic symptoms, and 0.33% for asymptomatic cases.
- Prior hemorrhage, male gender, and multiple ICMs were significant predictors of future hemorrhage, with risk decreasing over time.
Conclusions:
- The study provides estimates of prospective symptomatic hemorrhage risk in ICM patients, stratified by initial presentation.
- Prior hemorrhage, male gender, and multiplicity of ICMs are identified as potential predictors of future hemorrhage.
- Hemorrhage risk in patients with a history of symptomatic hemorrhage decreases over time.
Objective:
Our goal was to describe the prospective risk and timing of symptomatic hemorrhage in a large cohort of followed patients with intracerebral cavernous malformations (ICMs).
Methods:
All patients between 1989 and 1999 with the radiographic diagnosis of intracerebral cavernous malformation were identified retrospectively. The records and radiographic data were reviewed, and follow-up after diagnosis was obtained. An incidence rate was used to calculate annual risk of symptomatic hemorrhage. Predictive factors for outcomes used univariate and multivariable analysis with p < 0.05.
Results:
A total of 292 patients were identified (47.3%male) with 2,035 patient years of follow-up. Seventy-four patients presented with hemorrhage, 108 with symptoms not related to hemorrhage (seizure or focal deficit), and 110 as asymptomatic. The overall annual rate of hemorrhage in those presenting initially with hemorrhage, with symptoms not related to hemorrhage, or as an incidental finding was 6.19%, 2.18%, and 0.33%, respectively. Patients who presented initially with symptomatic hemorrhage (hazard ratio 5.14; 95% confidence interval [CI] 2.54-10.4; p < 0.001) were at higher risk for future hemorrhage, and hemorrhage risk decreased with time. Male gender (hazard ratio 2.36; 95% CI 1.14-4.89; p = 0.02), and multiplicity of ICMs (hazard ratio 2.65; 95% CI 1.30-5.43; p = 0.01) also increased the risk of hemorrhage. The median time from first to second hemorrhage was 8 months.
Conclusions:
This study provides an estimate of prospective annual symptomatic hemorrhage risk in patients with ICMs stratified by initial presenting symptom. Prior hemorrhage, male gender, and multiplicity of ICMs may predict future hemorrhage. Hemorrhage risk decreases with time in those initially presenting with hemorrhage.
Related Concept Videos
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Cerebral Edema ll: Pathophysiology
Increased Intracranial Pressure l: Introduction
Increased Intracranial Pressure ll: Pathophysiology

